Labcorp Holdings (NYSE:LH) is expanding its New York footprint through the acquisition of assets and operations from Crouse ...
Labcorp completes Crouse Health lab asset acquisition, taking over 12 patient service centers and inpatient lab operations in ...
Zacks Investment Research on MSN
Why Labcorp Holdings (LH) is a top value stock for the long term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
The deal, which will see Labcorp run 12 patient service centers, is part of the company’s ongoing efforts to expand through ...
Labcorp is continuing its push into New York as it has completed its acquisition of select assets of Crouse Health's ...
The yet-to-be-named new company will be publicly traded. Separating the laboratory testing work of LabCorp from the clinical trial services business, much of which came from acquisitions, will enable ...
A large regional health system has saved more than $5 million a year on labor and supplies—and even more with capital expense avoidance—by partnering with Labcorp. Within a period of one year, Labcorp ...
Labcorp is a global life sciences company headquartered in Burlington, North Carolina. Labcorp provides at-home test kits as well as in-person testing at their laboratory facilities, which are located ...
The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs along with other hospital-based testing services. Like its chief ...
Zacks Investment Research on MSN
Why is Labcorp (LH) down 4.6% since last earnings report?
It has been about a month since the last earnings report for Labcorp Holdings (LH). Shares have lost about 4.6% in that time ...
Medical testing giant LabCorp is still recovering from a ransomware attack nearly a week later, but won’t say just how the hackers got in nor how many servers were impacted. LabCorp was forced to shut ...
LabCorp is widening the availability of its blood test designed to detect whether someone has been exposed to the new coronavirus, CEO Adam Schechter told CNBC on Wednesday. The tests are "for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results